Pfeiffenberger Brent bought IPSC
November 19, 2025 · Form 4 insider transaction
Pfeiffenberger Brent bought 35,000 shares of Century Therapeutics, Inc. at $0.50 per share, a transaction worth $17.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
35,000
Price
$0.50
Total value
$17.3K
InsiderPfeiffenberger Brent
RoleOfficer, Director
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 19, 2025
Filing dateNovember 20, 2025
Shares owned after3,271,453
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
All profits from the reported transactions will be disgorged to the issuer pursuant to applicable requirements.; The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.488 to $0.5005. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.